AI assistant
Sending…
Aclaris Therapeutics, Inc. — Director's Dealing 2021
Dec 3, 2021
33670_dirs_2021-12-03_1d9bc59f-1868-4d5d-be15-f3904a5f214a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Aclaris Therapeutics, Inc. (ACRS)
CIK: 0001557746
Period of Report: 2021-11-23
Reporting Person: Powell Andrew Kenneth William (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-23 | Common Stock | G | 5500 | $0.00 | Disposed | 11209 | Direct |
More from Aclaris Therapeutics, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 28
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Major Shareholding Notification
2026
Mar 17
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26